Volume 4, Issue 2, December 2018, Page: 31-35
Oral Squamous Cell Carcinoma Associated withPapillon-Lefevre Syndrome: Systematic Review and the First Reported Case
Manar A. Abdul Aziz, Oral and Maxillofacial Pathology Department, Faculty of Dentistry, Cairo University, Cairo, Egypt
Mohamed A. Shawky, Oral and Maxillofacial Surgery Department, Faculty of Dentistry, Cairo University, Cairo, Egypt
Mohammed Atef, Oral and Maxillofacial Surgery Department, Faculty of Dentistry, Cairo University, Cairo, Egypt
Received: Aug. 28, 2018;       Accepted: Sep. 10, 2018;       Published: Oct. 10, 2018
DOI: 10.11648/j.ijdm.20180402.11      View  1392      Downloads  144
Papillon–Lefèvre syndrome (PLS) is a rare genodermatosis caused by mutation in CTSC gene which is expressed in epithelial cells as well as in various immune cells including PMNs, macrophages, and their precursors. Such mutation results in palmoplantar hyperkeratosis, early onset periodontitis, susceptibility to infection and rarely mucocutaneous carcinomas. In this study, we aim to perform a systematic review on the incidence of oral squamous cell carcinoma in the association with Papillon-Lefevre syndrome and to introduce the first case report. An electronic search without date and language restrictions in three data bases, Pubmed, Cochrane Library, and Google Scholar in addition to a hand-searching were performed in August 2018. The review of the current literature revealed that such association has not been previously reported. We concluded that patients with Papillon-Lefevre syndrome are susceptible to develop different mucocutaneous carcinomas including OSCC.
Papillon-Lefevre Syndrome, Oral Squamous Cell Carcinoma, Palmoplantar Keratosis, Periodontitis
To cite this article
Manar A. Abdul Aziz, Mohamed A. Shawky, Mohammed Atef, Oral Squamous Cell Carcinoma Associated withPapillon-Lefevre Syndrome: Systematic Review and the First Reported Case, International Journal of Dental Medicine. Vol. 4, No. 2, 2018, pp. 31-35. doi: 10.11648/j.ijdm.20180402.11
Copyright © 2018 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Sreeramulu B, Shyam N, Ajay P and Suman P. Papillon–Lefèvre syndrome: clinical presentation and management options.Clin Cosmet Investig Dent. 2015; 7: 75–81. doi: 10.2147/CCIDE.S76080.
Pavankumar K. Papillon–Lefevre syndrome: A case report. The Saudi Dent J 2010; 22: 95-8. doi: 10.1016/j.sdentj.2010.02.009. Epub 2010 Feb 6.
Ragupathy K, Priyadharsini I, Pasupathy S. Parental Consanguinity as a Risk Factor in Papillon-Lefevre Syndrome: A Case Report. Int J Dent Med Res 2015; 1: 68-71. www.ijohmr.com/.../Parental%20Consanguinity%20as%20a%20Risk.
Sammy Al-Benna,1 Raphael Hasler,1 Ingo Stricker,2 Hans-Ulrich Steinau,1 and Lars Steinstraesser. Papillon-Lefèvre syndrome and squamous cell carcinoma: a case report. Cases J. 2009; 2: 7067. doi: 10.4076/1757-1626-2-7067.
Hacham-Zadeh S, Goldberg L. Malignant melanoma and Papillon-Lefvre syndrome. Arch Dermatol. 1982; 118(1): 2. doi:10.1001/archderm.1982.01650130006003.
Nakajima K, Nakano H, Takiyoshi N, Rokunohe A, Ikenaga S, Aizu T, Kaneko T, Mitsuhashi Y, Sawamura D. Papillon Lefèvre syndrome and malignant melanoma. A high incidence of melanoma development in Japanese palmoplantar keratoderma patients. Dermatology. 2008; 217(1): 58-62. doi: 10.1159/000124340.
Cook GP. Papillon-Lefèvre syndrome and malignant melanoma. Dermatology. 2009; 219(2):187-8. doi: 10.1159/000224432.
T. Chaubal, R. Bapat and P. Wadkar. Papillon Lefevre syndrome. QJM. 2017; 110: 527, https://doi.org/10.1093/qjmed/hcx090.
Ikeshima A. Papillon-Lefevre syndrome: a highly-suspected case. Journal of oral science 2006; 48: 257-60. https://www.slideshare.net/.../papillonlefevre-syndrome-a-case-report.
Murthy R, Honavar SG, Vemuganti GK, Burman S, Naik M, Parathasaradhi A. Ocular surface squamous neoplasia in Papillon-Lefevre syndrome. Am J Ophthalmol. 2005 Jan; 139(1): 207-9. DOI:10.1016/j.ajo.2004.07.028.
Babu N A, Rajesh E, Krupaa J and Gnananandar G. Genodermatoses. J Pharm Bioallied Sci. 2015; 7: 203–6. DOI: 10.4103/0975-7406.155903.
Ghaffari J, Rezaee S. Gharagozlou M. Chédiak–Higashi syndrome. J Pediatr Rev. 2013; 1: 80-7. http://jpr.mazums.ac.ir/article-1-49-en.html
Bullón P, Castejón-Vega B, Román-Malo L, Jimenez-Guerrero MP, Cotán D, Forbes-Hernandez TY, Varela-López A, Pérez-Pulido AJ, Giampieri F, Quiles JL, Battino M, Sánchez-Alcázar JA, Cordero MD. Autophagic dysfunction in patients with Papillon-Lefèvre syndrome is restored by recombinant cathepsin C treatment. J Allergy Clin Immunol. 2018: S0091-6749(18)30144-1. doi: 10.1016/j.jaci.2018.01.018.
García MSF and Teruya-Feldstein J. The diagnosis and treatment of dyskeratosis congenita: a review. J Blood Med. 2014; 5: 157–67. DOI_1048_Kutbay.
Bouckaert M, Munzhelele TI , Feller L , Lemmer J and Khammissa RAG. The clinical characteristics of oral squamous cell carcinoma in patients attending the Medunsa Oral Health Centre, South Africa. Integr Cancer Sci Therap, 2016; 3: 575-8. DOI: 10.15761/ICST.1000207.
Browse journals by subject